San Diego, CA – NVIDIA has officially launched the BioNeMo agent toolkit, a groundbreaking suite of tools specifically engineered to…
Read More
Salesforce lands 140 life sciences clients, pitches ‘headless’ AI to pharma
In a significant move underscoring the escalating competition in the life sciences technology sector, Salesforce announced that over 140 life…
Read More
Salesforce lands 140 life sciences clients, pitches ‘headless’ AI to pharma
In a strategic maneuver that underscores the intensifying competition in the life sciences technology sector, Salesforce has announced that over…
Read More
Sai Life Sciences Galvanizes Early-Stage Biotech Innovation with Landmark 2026 Pitch Day in Boston
Sai Life Sciences, a global contract research, development, and manufacturing organization (CRDMO), recently convened its highly anticipated Biotech Pitch Day…
Read More
OpenBench and Concept Life Sciences Forge Strategic Alliance to Revolutionize Early-Stage Drug Discovery with Fee-for-Success Model
A groundbreaking strategic partnership has been announced between OpenBench, a pioneer in AI-driven drug discovery, and Concept Life Sciences, a…
Read More
Gilead Sciences Finalizes $5 Billion Acquisition of Tubulis, Bolstering Oncology Pipeline with Advanced ADC Technology
Gilead Sciences has officially completed its acquisition of Tubulis, a prominent German biotechnology firm specializing in the development of next-generation…
Read More
Gilead Sciences Pledges Over 400,000 Doses of AmBisome to Combat Visceral Leishmaniasis, Extending Vital Global Health Partnership
Gilead Sciences has announced a significant commitment to global health, pledging over 400,000 doses of its vital antifungal medication, AmBisome…
Read More
Sai Life Sciences’ Biotech Pitch Day 2026 Unveils Groundbreaking Innovations from Early-Stage Biotechs, Reinforcing Global Drug Discovery Ecosystem
Sai Life Sciences, a leading global contract research, development, and manufacturing organization (CRDMO), recently convened its highly anticipated Biotech Pitch…
Read More
Sai Life Sciences’ Biotech Pitch Day 2026 Ignites Innovation with Promising Early-Stage Biotech Ventures
Sai Life Sciences, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), recently convened its highly anticipated Biotech Pitch…
Read More
Gilead Sciences Reports Robust Q1 2026 Performance Driven by Strong HIV Portfolio and Promising PrEP Launches
Gilead Sciences has commenced 2026 with a demonstrably strong first quarter, reporting significant revenue growth primarily fueled by its leading…
Read More
